VAD regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:VAD Regimen; Vincristine-Adriamycin-Dexamethasone Regimen
Overview
Overview
VAD regimen refers to a regimen consisting of vincristine, doxorubicin (adriamycin) and dexamethasone used as induction treatment for multiple myeloma.[1][2]
Regimen
Regimen
VVincristine
ADoxorubicin (Adriamycin)
DDexamethasone
References
References
- ↑ “NCI Thesaurus”.
- ↑ 2.0 2.1 Wan J (2013). “[Therapeutic efficacy analysis of VD regimen and VAD regimen for multiple myeloma]”. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 21 (3): 647–9. doi:10.7534/j.issn.1009-2137.2013.03.022. PMID 23815915.
- ↑ “NCI Thesaurus”.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
